Nystatin
- Product NDC
- 0904-7276
- 11-digit product format
- 009047276
- Labeler code
- 0904
- Product ID
- 0904-7276_764e2a6a-00ef-4340-8810-9537bae3b0be
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- NYSTATIN
- Dosage form
- SUSPENSION
- Route
- ORAL
- Labeler
- Major Pharmaceuticals
- Application
- ANDA203621
- Marketing category
- ANDA
- Marketing start
- 2020-07-17
- Substance
- NYSTATIN
- Active strength
- 100000 [USP'U]/mL
- Pharmacologic classes
- Polyene Antifungal [EPC], Polyenes [CS]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A203621-001 | NYSTATIN | NYSTATIN | 100,000 UNITS/ML | SUSPENSION / ORAL | AA | 2016-01-07 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A203621-001 | AA |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | A203621-001 | NYSTATIN | 100,000 UNITS/ML | SUSPENSION / ORAL | AA | 2016-01-07 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A203621-001 | NYSTATIN | 100,000 UNITS/ML | SUSPENSION / ORAL | AA | 2016-01-07 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A203621-001 | NYSTATIN | 100,000 UNITS/ML | SUSPENSION / ORAL | AA | 2016-01-07 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A203621-001 | NYSTATIN | 100,000 UNITS/ML | SUSPENSION / ORAL | AA | 2016-01-07 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A203621-001 | NYSTATIN | 100,000 UNITS/ML | SUSPENSION / ORAL | AA | 2016-01-07 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A203621-001 | NYSTATIN | 100,000 UNITS/ML | SUSPENSION / ORAL | AA | 2016-01-07 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A203621-001 | NYSTATIN | 100,000 UNITS/ML | SUSPENSION / ORAL | AA | 2016-01-07 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A203621-001 | NYSTATIN | 100,000 UNITS/ML | SUSPENSION / ORAL | AA | 2016-01-07 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A203621-001 | NYSTATIN | 100,000 UNITS/ML | SUSPENSION / ORAL | AA | 2016-01-07 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A203621-001 | NYSTATIN | 100,000 UNITS/ML | SUSPENSION / ORAL | AA | 2016-01-07 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A203621-001 | NYSTATIN | 100,000 UNITS/ML | SUSPENSION / ORAL | AA | 2016-01-07 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A203621-001 | NYSTATIN | 100,000 UNITS/ML | SUSPENSION / ORAL | AA | 2016-01-07 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A203621-001 | NYSTATIN | 100,000 UNITS/ML | SUSPENSION / ORAL | AA | 2016-01-07 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A203621-001 | NYSTATIN | 100,000 UNITS/ML | SUSPENSION / ORAL | AA | 2016-01-07 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | A203621-001 | NYSTATIN | 100,000 UNITS/ML | SUSPENSION / ORAL | AA | 2016-01-07 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A203621-001 | NYSTATIN | 100,000 UNITS/ML | SUSPENSION / ORAL | AA | 2016-01-07 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | A203621-001 | NYSTATIN | 100,000 UNITS/ML | SUSPENSION / ORAL | AA | 2016-01-07 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | A203621-001 | NYSTATIN | 100,000 UNITS/ML | SUSPENSION / ORAL | AA | 2016-01-07 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | A203621-001 | NYSTATIN | 100,000 UNITS/ML | SUSPENSION / ORAL | AA | 2016-01-07 | 74a2ff9319b5… | |
| 2022-03-09 01:35 UTC | 2022-03 | A203621-001 | NYSTATIN | 100,000 UNITS/ML | SUSPENSION / ORAL | AA | 2016-01-07 | bb7c543d1eb4… | |
| 2021-12-28 21:50 UTC | 2021-12 | A203621-001 | NYSTATIN | 100,000 UNITS/ML | SUSPENSION / ORAL | AA | 2016-01-07 | 782e0a99824c… | |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A203621-001 | NYSTATIN | 100,000 UNITS/ML | SUSPENSION / ORAL | AA | 2016-01-07 | 87673890dc5c… | |
| 2021-03-12 10:30 UTC | 2021-03 | A203621-001 | NYSTATIN | 100,000 UNITS/ML | SUSPENSION / ORAL | AA | 2016-01-07 | 5aa47cf7b7d7… | |
| 2020-12-22 03:56 UTC | 2020-12 | A203621-001 | NYSTATIN | 100,000 UNITS/ML | SUSPENSION / ORAL | AA | 2016-01-07 | 8869cabd3fbd… | |
| 2020-11-12 02:37 UTC | 2020-11 | A203621-001 | NYSTATIN | 100,000 UNITS/ML | SUSPENSION / ORAL | AA | 2016-01-07 | c0c555d07b60… | |
| 2019-12-14 00:12 UTC | 2019-12 | A203621-001 | NYSTATIN | 100,000 UNITS/ML | SUSPENSION / ORAL | AA | 2016-01-07 | 3f01610625f2… | |
| 2019-09-15 20:21 UTC | 2019-09 | A203621-001 | NYSTATIN | 100,000 UNITS/ML | SUSPENSION / ORAL | AA | 2016-01-07 | b00525d2431f… | |
| 2019-07-19 19:46 UTC | 2019-07 | A203621-001 | NYSTATIN | 100,000 UNITS/ML | SUSPENSION / ORAL | AA | 2016-01-07 | ea99ee380514… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A203621-001 | NYSTATIN | 100,000 UNITS/ML | SUSPENSION / ORAL | AA | 2016-01-07 | 6a51e52b5d6a… | |
| 2024-02-18 07:12 UTC | 2024-02 | A203621-001 | NYSTATIN | 100,000 UNITS/ML | SUSPENSION / ORAL | AA | 2016-01-07 | 1c564ffb4f44… | |
| 2023-12-20 04:57 UTC | 2023-12 | A203621-001 | NYSTATIN | 100,000 UNITS/ML | SUSPENSION / ORAL | AA | 2016-01-07 | ea1830bbd6c7… | |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A203621-001 | NYSTATIN | 100,000 UNITS/ML | SUSPENSION / ORAL | AA | 2016-01-07 | a72a2bbeb626… | |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A203621-001 | NYSTATIN | 100,000 UNITS/ML | SUSPENSION / ORAL | AA | 2016-01-07 | 9b2671bbb829… | |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A203621-001 | NYSTATIN | 100,000 UNITS/ML | SUSPENSION / ORAL | AA | 2016-01-07 | a67488948f0b… | |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A203621-001 | NYSTATIN | 100,000 UNITS/ML | SUSPENSION / ORAL | AA | 2016-01-07 | 3f0d92c62455… | |
| 2023-05-13 08:27 UTC | 2023-05 | A203621-001 | NYSTATIN | 100,000 UNITS/ML | SUSPENSION / ORAL | AA | 2016-01-07 | 053a50430f4f… | |
| 2023-01-26 05:58 UTC | 2023-01 | A203621-001 | NYSTATIN | 100,000 UNITS/ML | SUSPENSION / ORAL | AA | 2016-01-07 | 3bdfa0b2c4d7… | |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A203621-001 | NYSTATIN | 100,000 UNITS/ML | SUSPENSION / ORAL | AA | 2016-01-07 | 3a93d1ddd44b… | |
| 2022-10-28 04:53 UTC | 2022-10 | A203621-001 | NYSTATIN | 100,000 UNITS/ML | SUSPENSION / ORAL | AA | 2016-01-07 | f41ea6bd6efb… | |
| 2022-09-29 23:25 UTC | 2022-09 | A203621-001 | NYSTATIN | 100,000 UNITS/ML | SUSPENSION / ORAL | AA | 2016-01-07 | e64feba35796… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | A203621-001 | AA | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A203621-001 | AA | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A203621-001 | AA | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A203621-001 | AA | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A203621-001 | AA | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A203621-001 | AA | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A203621-001 | AA | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A203621-001 | AA | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A203621-001 | AA | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A203621-001 | AA | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A203621-001 | AA | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A203621-001 | AA | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A203621-001 | AA | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A203621-001 | AA | 1 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A203621-001 | AA | 1 | 8072bd15b7f6… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A203621-001 | AA | 1 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | A203621-001 | AA | 1 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | A203621-001 | AA | 1 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | A203621-001 | AA | 1 | 74a2ff9319b5… |
| 2022-03-09 01:35 UTC | 2022-03 | A203621-001 | AA | 1 | bb7c543d1eb4… |
| 2021-12-28 21:50 UTC | 2021-12 | A203621-001 | AA | 1 | 782e0a99824c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A203621-001 | AA | 1 | 87673890dc5c… |
| 2021-03-12 10:30 UTC | 2021-03 | A203621-001 | AA | 1 | 5aa47cf7b7d7… |
| 2020-12-22 03:56 UTC | 2020-12 | A203621-001 | AA | 1 | 8869cabd3fbd… |
| 2020-11-12 02:37 UTC | 2020-11 | A203621-001 | AA | 1 | c0c555d07b60… |
| 2019-12-14 00:12 UTC | 2019-12 | A203621-001 | AA | 1 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | A203621-001 | AA | 1 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | A203621-001 | AA | 1 | ea99ee380514… |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A203621-001 | AA | 1 | 6a51e52b5d6a… |
| 2024-02-18 07:12 UTC | 2024-02 | A203621-001 | AA | 1 | 1c564ffb4f44… |
| 2023-12-20 04:57 UTC | 2023-12 | A203621-001 | AA | 1 | ea1830bbd6c7… |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A203621-001 | AA | 1 | a72a2bbeb626… |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A203621-001 | AA | 1 | 9b2671bbb829… |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A203621-001 | AA | 1 | a67488948f0b… |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A203621-001 | AA | 1 | 3f0d92c62455… |
| 2023-05-13 08:27 UTC | 2023-05 | A203621-001 | AA | 1 | 053a50430f4f… |
| 2023-01-26 05:58 UTC | 2023-01 | A203621-001 | AA | 1 | 3bdfa0b2c4d7… |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A203621-001 | AA | 1 | 3a93d1ddd44b… |
| 2022-10-28 04:53 UTC | 2022-10 | A203621-001 | AA | 1 | f41ea6bd6efb… |
| 2022-09-29 23:25 UTC | 2022-09 | A203621-001 | AA | 1 | e64feba35796… |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Nystatin
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| NYSTATIN | 100000 [USP'U]/mL |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| BDF1O1C72E | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 312055 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 17b9e33d-da9c-467a-bbc4-9e257727f19a | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| e29fe634-dc25-094c-c77f-5d09c3eceb3e | Product name | 5 | 20260107 |
| efd58dcf-540a-4531-8766-e713129ca6f2 | Product name | 1 | 20250307 |
| e57b6340-9387-3f9a-7307-511c81791375 | Product name | 3 | 20221214 |
| 544f8e8d-6389-eeeb-9586-aa447c08dcc7 | Product name | 5 | 20210614 |
| 1629e00f-54fb-4a43-8306-b58442b23902 | Product name | 9 | 20200430 |
| 854ec07b-1cd7-a5db-235a-7aa24d3cf97a | Product name | 3 | 20180628 |
| 19b9f4c1-15e9-edcc-4c16-f01ecfb5c549 | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0904-7276-41 | Nystatin | 5 mL in 1 CUP, UNIT-DOSE | SUSPENSION | 5 | 7 | |
| 0904-7276-70 | Nystatin | 10 in 1 CASE | SUSPENSION | 10 | 7 | |
| 0904-7276-70 | Nystatin | 10 in 1 TRAY | SUSPENSION | 10 | 7 | |
| 0904-7276-92 | Nystatin | 5 in 1 CASE | SUSPENSION | 5 | 7 | |
| 0904-7276-92 | Nystatin | 10 in 1 TRAY | SUSPENSION | 10 | 7 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0904-7276-41 | ML - Milliliter | 0904-7276 | 96e2ec22-526d-48c6-88ae-1ae44083a2af | 1 | 2022-12-07 |
| 0904-7276-70 | ML - Milliliter | 0904-7276 | 10302933-43ab-48c8-a467-039534481bd1 | 1 | 2022-12-07 |
| 0904-7276-92 | ML - Milliliter | 0904-7276 | 2a070892-5792-41ba-aff7-624e85e3245b | 1 | 2022-12-07 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Nystatin | NYSTATIN | PAI Holdings, LLC dba PAI Pharma | 28b4e26e-206a-4e8a-abfe-774b780e91c3 | 2026-07-21 | Adverse reactions | 203621 ANDA203621 |
| Nystatin | NYSTATIN | Cardinal Health 107, LLC | d59098da-1395-49fb-9fd6-947bbbeed56f | 2026-02-26 | Adverse reactions | 203621 ANDA203621 |
| Nystatin | NYSTATIN | Major Pharmaceuticals | 17b9e33d-da9c-467a-bbc4-9e257727f19a | 2026-02-23 | Adverse reactions | 203621 ANDA203621 0904-7276 |
| Nystatin | NYSTATIN | Cardinal Health 107, LLC | 56aca0e2-8691-4701-beba-e2315524709f | 2025-10-23 | Adverse reactions | 203621 ANDA203621 |
| Nystatin | NYSTATIN | PAI Holdings, LLC dba PAI Pharma | 05a8b8b6-3639-47b8-b7fc-47b105f5e6f9 | 2024-07-16 | Adverse reactions | 203621 ANDA203621 |
| Nystatin | NYSTATIN | American Health Packaging | d8c251a6-d4da-4664-bff4-6868541d1178 | 2024-02-22 | Adverse reactions | 203621 ANDA203621 |
| Nystatin | NYSTATIN | A-S Medication Solutions | cc3516cd-985c-489f-b4a1-8477876c5a97 | 2023-10-19 | Adverse reactions | 203621 ANDA203621 |
| Nystatin | NYSTATIN | Pharmaceutical Associates, Inc. | 31e3da10-5a7b-4bc5-8a4f-3e786b64c13a | 2022-01-13 | Adverse reactions | 203621 ANDA203621 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 312055 | nystatin 100,000 UNT/mL Oral Suspension | PSN | 17b9e33d-da9c-467a-bbc4-9e257727f19a | 7 |
| 312055 | nystatin 100000 UNT/ML Oral Suspension | SCD | 17b9e33d-da9c-467a-bbc4-9e257727f19a | 7 |
| 312055 | nystatin 100,000 UNT/ML Oral Suspension | SY | 17b9e33d-da9c-467a-bbc4-9e257727f19a | 7 |
| 312055 | nystatin 500,000 UNT per 5 ML Oral Suspension | SY | 17b9e33d-da9c-467a-bbc4-9e257727f19a | 7 |
| 312055 | nystatin 100,000 UNT/mL Oral Suspension | PSN | 56aca0e2-8691-4701-beba-e2315524709f | 4 |
| 312055 | nystatin 100000 UNT/ML Oral Suspension | SCD | 56aca0e2-8691-4701-beba-e2315524709f | 4 |
| 312055 | nystatin 100,000 UNT/ML Oral Suspension | SY | 56aca0e2-8691-4701-beba-e2315524709f | 4 |
| 312055 | nystatin 500,000 UNT per 5 ML Oral Suspension | SY | 56aca0e2-8691-4701-beba-e2315524709f | 4 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 0904-7276-41 | 00904727641 | 5 mL in 1 CUP, UNIT-DOSE | 5 ml | Historical | ||||
| 0904-7276-70 | 00904727670 | 10 TRAY in 1 CASE (0904-7276-70) / 10 CUP, UNIT-DOSE in 1 TRAY / 5 mL in 1 CUP, UNIT-DOSE (0904-7276-41) | 10 tray | 2022-11-28 | 0000-00-00 | No | No | Current |
| 0904-7276-92 | 00904727692 | 5 TRAY in 1 CASE (0904-7276-92) / 10 CUP, UNIT-DOSE in 1 TRAY / 5 mL in 1 CUP, UNIT-DOSE (0904-7276-41) | 5 tray | 2022-11-28 | 0000-00-00 | No | No | Current |